Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
- Posted on May 29, 2026
- By CNBC
- 1 Views
- 1 min read
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.